BA, Drake University; JD, Washington University Law School
As the Senior Analyst on the Defense and Aerospace Companies Briefing for Teal Group Corporation, Renée J. Gentry consulted for the U.S. Government, French Government, and major prime contractors on European defense industry consolidation, antitrust issues, specific defense market overviews for product development, and profiles of companies designed to assist management in acquisition activities. After leaving Teal Group, she worked as principal liaison to corporate clients, as well as the Washington National Opera and Domingo-Cafritz Young Artists Program, advising them on a range of immigration issues. She has practiced vaccine litigation since 2001.
Renée J. Gentry is a named partner with Shoemaker, Gentry & Knickelbein in Vienna, VA. She is one of the leading experts on vaccine injury litigation in the National Vaccine Injury Compensation Program (NVICP).
Ms. Gentry has advised numerous congressional members, staff, and committees on issues relevant to the NVICP, and she has also helped to draft proposed legislation. She is licensed to practice law in the District of Columbia and is admitted to the Federal Claims Court Bar. Ms. Gentry is the Co-Director of the Vaccine Injury Legal Clinic at George Washington University Law School and currently serves as President of the Vaccine Injured Petitioners Bar Association, a national bar representing the interests of claimants in the NVICP. She is a member of the U.S. Court of Federal Claims Bar Association and the American Association for Justice (formerly ATLA).